This website uses cookies to enhance the user experience.
P

PHOTOCURE ASA967 598 593

Research
Public limited company
Hoffsveien 4 0275 OSLO, Norge

PHOTOCURE ASA

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
29 years
since Feb 20, 1995
Type
Public limited company
VAT registered
Yes
Number of employees
20

Ownership

Number of shares and share classes
27,120,820
1 share class
Total number of shareholders
4410
295 companies, 4,115 persons

Financials

Total operating income 2023
334,724,000
NOK
Annual total result 2023
-3,557,000
NOK
Total equity 2023
791,294,000
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
Chairman-
Board Member-

Others

NameRoleShares
K
KPMG AS
Auditor-
Last update: Nov 12, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
NO0010000045
4,189,053
15.45 %
NO0010000045
1,920,000
7.08 %
NO0010000045
1,205,319
4.44 %
NO0010000045
1,019,101
3.76 %
NO0010000045
799,178
2.95 %
NO0010000045
782,677
2.89 %
M
MP PENSJON PK
NO0010000045
661,093
2.44 %
NO0010000045
625,987
2.31 %
NO0010000045
621,745
2.29 %
NO0010000045
458,572
1.69 %
NO0010000045
426,887
1.57 %
NO0010000045
375,630
1.39 %
NO0010000045
274,140
1.01 %
NO0010000045
271,500
1 %
NO0010000045
262,609
0.97 %
N
NORDNET LIVSFORSIKRING AS
NO0010000045
256,181
0.94 %
NO0010000045
253,908
0.94 %
NO0010000045
238,101
0.88 %
S
SPARLI AS
NO0010000045
215,000
0.79 %
NO0010000045
200,000
0.74 %
NO0010000045
192,684
0.71 %
NO0010000045
189,340
0.7 %
NO0010000045
179,412
0.66 %
NO0010000045
170,235
0.63 %
B
BEELINE AS
NO0010000045
169,894
0.63 %
NO0010000045
166,869
0.62 %
NO0010000045
156,496
0.58 %
NO0010000045
151,318
0.56 %
A
A/S Skarv
NO0010000045
150,000
0.55 %
V
VICAMA AS
NO0010000045
150,000
0.55 %
NO0010000045
138,527
0.51 %
N
NESMOEN INVEST AS
NO0010000045
128,000
0.47 %
NO0010000045
126,239
0.47 %
P
PRO AS
NO0010000045
114,788
0.42 %
NO0010000045
114,046
0.42 %
NO0010000045
113,703
0.42 %
NO0010000045
111,000
0.41 %
M
MUSTANG CAPITAL AS
NO0010000045
110,000
0.41 %
C
CORTEX AS
NO0010000045
100,000
0.37 %
NO0010000045
98,700
0.36 %
NO0010000045
94,815
0.35 %
NO0010000045
90,946
0.34 %
NO0010000045
90,000
0.33 %
NO0010000045
90,000
0.33 %
NO0010000045
86,660
0.32 %
T
TOTAKTER AS
NO0010000045
80,000
0.29 %
NO0010000045
79,039
0.29 %
NO0010000045
78,768
0.29 %
NO0010000045
71,944
0.27 %
NO0010000045
64,211
0.24 %
NO0010000045
63,151
0.23 %
P
POCKET VALLEY AS
NO0010000045
63,000
0.23 %
NO0010000045
62,112
0.23 %
NO0010000045
61,878
0.23 %
NO0010000045
61,000
0.22 %
NO0010000045
60,010
0.22 %
NO0010000045
58,608
0.22 %
NO0010000045
56,700
0.21 %
NO0010000045
55,000
0.2 %
NO0010000045
53,574
0.2 %
NO0010000045
53,000
0.2 %
F
FORENEDE FORVALTNING AS
NO0010000045
51,020
0.19 %
J
NO0010000045
50,000
0.18 %
NO0010000045
48,898
0.18 %
NO0010000045
47,026
0.17 %
B
BORGUND INVEST AS
NO0010000045
47,000
0.17 %
NO0010000045
46,657
0.17 %
NO0010000045
45,846
0.17 %
NO0010000045
45,000
0.17 %
L
LUCELLUM AS
NO0010000045
45,000
0.17 %
L
LOCA AS
NO0010000045
45,000
0.17 %
NO0010000045
44,648
0.16 %
NO0010000045
43,508
0.16 %
P
PIVOT INVEST 2 AS
NO0010000045
43,089
0.16 %
NO0010000045
42,651
0.16 %
M
MAGNUS DEN GODE AS
NO0010000045
42,323
0.16 %
NO0010000045
42,128
0.16 %
NO0010000045
41,500
0.15 %
J
JAD INVEST AS
NO0010000045
41,439
0.15 %
NO0010000045
41,056
0.15 %
T
TTC INVEST AS
NO0010000045
40,000
0.15 %
AM
NO0010000045
40,000
0.15 %
H
HANDSAFE AS
NO0010000045
40,000
0.15 %
M
MYNA AS
NO0010000045
39,153
0.14 %
K
KAPRIFOL AS
NO0010000045
39,001
0.14 %
S
SKIHUS AS
NO0010000045
39,000
0.14 %
JB
NO0010000045
38,243
0.14 %
EM
NO0010000045
38,129
0.14 %
NO0010000045
37,425
0.14 %
NO0010000045
36,470
0.13 %
NO0010000045
36,350
0.13 %
NO0010000045
36,223
0.13 %
V
VK INVEST AS
NO0010000045
35,069
0.13 %
NO0010000045
35,000
0.13 %
H
HERIKLA AS
NO0010000045
35,000
0.13 %
I
INFIX AS
NO0010000045
34,000
0.13 %
NO0010000045
33,862
0.12 %
T
TRIVON AS
NO0010000045
33,000
0.12 %
ED
NO0010000045
32,750
0.12 %
NO0010000045
31,846
0.12 %

Shares owned by the PHOTOCURE ASA

NameShare classNumber of sharesShare
P
PHOTOCURE ASA
NO0010000045
15,122
0.06 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year2023
Total operating income
334,724,000
Annual Total Result
-3,557,000
Total assets
1,006,752,000
Total liabilities
215,458,000
Total equity
791,294,000

P&L

Year2023
Total operating income
334,724,000
Total operating costs
319,934,000
Operating result
14,790,000
Financial income/costs
-12,703,000
Profit before tax
2,087,000
Total tax & extraordinary income/cost
5,644,000
Annual Total Result
-3,557,000

Balance overview

Year2023
Total fixed assets
682,219,000
Total current assets
324,533,000
Total assets
1,006,752,000
Short term debt
79,202,000
Long term debt
136,256,000
Total liabilities
215,458,000
Contributed capital
474,133,000
Retained earnings
317,161,000
Total equity
791,294,000
Total equity and liabilities
1,006,752,000

Classification

Category
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology